Rosemont Pharmaceuticals
Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees
Rosemont Pharmaceuticals is a pharmaceutical manufacturing company focused on rapid development, reliable production, and global supply of novel-delivery medicines designed with patient needs in mind. The company has built a reputation for supporting patients with swallowing difficulties, advocating liquid medications over manipulation of solid-dose forms, and producing educational resources for healthcare professionals on medication management challenges. Its portfolio includes more than 130 oral liquid medicines across multiple therapeutic areas, with around 70 licensed products, and all items are manufactured to GMP standards. The UK range includes nine products licensed for use with PEG or NG tubes, and Rosemont aims to expand its licensed offerings by converting more specials where possible. Based in Leeds, England, Rosemont operates within the pharmaceutical manufacturing industry and serves healthcare professionals and patients who rely on liquid formulations. The company positions itself as a specialized provider of liquid medicines, addressing the needs of patients with swallowing difficulties and promoting best practices in the administration of liquid medications. In August 2024, Rosemont announced an asset investment in a Greek contract development and manufacturing organization and acquired a Greek CDMO, expanding its manufacturing footprint in Southern Europe.